ITL Biomedical
Private Company
Funding information not available
Overview
ITL BioMedical is a privately held, commercial-stage medical device company headquartered in Baltimore, USA, with a significant operational presence in Australia. The company has established itself in the niche markets of needle safety and sample management, offering a range of patented products like the SampLok sampling system and Safety SubCulture Unit. With over 300 employees, a portfolio of 50 patents, and a global commercial footprint in over 55 countries, ITL BioMedical focuses on reducing healthcare-associated risks through ergonomic and innovative device design. It operates on a product sales business model, generating revenue from direct sales of its medical and veterinary devices.
Technology Platform
Mechanical safety engineering and ergonomic fluid-path design for medical devices, focused on needle safety, closed-system sample transfer, and contamination prevention. Protected by 50 patents.
Opportunities
Risk Factors
Competitive Landscape
ITL BioMedical competes in specialized segments against both large medical device conglomerates (e.g., Becton Dickinson, Cardinal Health, Thermo Fisher) and smaller niche players. Its competitive advantage lies in its deep focus on specific safety procedures, a strong IP portfolio, and products tailored to the nuanced needs of blood banks, microbiology labs, and veterinary practices.